Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ).
Jubilant Pharmova Limited has submitted a confirmation certificate to the stock exchanges in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending June 30, 2025. This certificate, received from Alankit Assignments Limited, confirms that the company’s securities have been listed on the stock exchanges, and the physical share certificates have been duly verified, mutilated, and canceled, with the depository’s name substituted as the registered owner. This move ensures compliance with regulatory requirements and reinforces the company’s commitment to maintaining transparency and proper record-keeping.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is involved in providing innovative healthcare solutions and has a significant presence in the global pharmaceutical market.
Average Trading Volume: 16,178
Current Market Cap: 190.8B INR
Find detailed analytics on JUBLPHARMA stock on TipRanks’ Stock Analysis page.